Bioz Grants FREE Access to All Researchers in Biopharma and Academia to Accelerate the Fight Against COVID-19
LOS ALTOS, Calif., March 19, 2020 (Newswire.com) - Bioz, Inc., a Silicon Valley AI company for life science research, effective today, is stepping up to do its part in the fight against COVID-19 by granting free access to the full Bioz.com platform to all biopharma companies; researchers in academia already have free access to Bioz.com. COVID-19 has magnified the importance of scientific research, because without research, health is not possible. By providing biopharma researchers with free access to the award-winning Bioz platform, Bioz is providing strong support in the fight against the COVID-19 outbreak that is changing the way we all think and work.
Bioz’s patented semantic recommendation engine was developed over six years by a world-renowned engineering team, supported by three Nobel Prize winners in chemistry: Prof. Ada Yonath, Prof. Roger Kornberg and Prof. Michael Levitt. What used to take scientists months, now takes them mere minutes with Bioz, 82x times faster than before. By accelerating the pace of experiments, Bioz is accelerating the pace of drug discovery by as much as 50%.
Daniel Levitt, founder and CEO of Bioz, states, “Researchers who are working around the clock at biotech and pharmaceutical companies worldwide can now leverage our tremendous wealth of research knowledge to fight the novel coronavirus.” Levitt further added that “Bioz is firmly committed to accelerating the pace of research towards an effective SARS-CoV-2 vaccine and the development of a cure for COVID-19 by giving researchers free access to the world’s most comprehensive and objective recommendation engine for life science experimentation.”
As we speak, members of the global scientific community are working tirelessly to find new ways to fight this pandemic. Working fast and effectively is critical for global efforts to succeed and the Bioz platform facilitates better choices that accelerate successful experimentation. With its industry-standard Bioz Stars ratings, Bioz guides researchers to quickly choose the best experimentation techniques and products (reagents, biologicals, chemicals, instruments and tools) to battle the novel coronavirus. Bioz empowers researchers to focus on their difficult task by leveraging the comprehensiveness, objectivity, and transparency that Bioz provides.
Dr. Karin Lachmi, founder and CSO of Bioz, states, "During such times, I feel proud to be at a company that is so actively and directly supporting scientific research and the discovery of a vaccine for the SARS-CoV-2 virus and treatments for COVID-19." Dr. Lachmi further added that “it is the order of the moment to support and empower researchers to quickly find both a cure and a vaccine. Bioz was founded to support faster research using advanced AI technology and to give researchers the tools to win battles against emerging pathogens like what we are facing today.”
Suggested Tweet: @Bioz grants FREE access to all researchers to accelerate the fight against COVID-19. https://bit.ly/2U21Kfy
Helpful Links
Media Contact:
[email protected]
Source: Bioz, Inc.
Share:
Tags: biotech, bioz, coronavirus, covid-19, covid19, drug discovery, pandemic, pharma, research, rna virus, sars-cov-2, science
